Mumbai [India], Nov.21 : Capturing the latest trends in health and nutrition, DuPont presents a wide range of probiotic strains and blends to help develop products that differentiate.
Customers will now have an opportunity to expedite innovative new products to market in over-the-counter (OTC) nutrition supplements and pharmaceutical product categories in South Asia.
End consumers will benefit from the well-researched strain portfolio of DuPont Danisco FloraFIT customizable probiotics and HOWARU premium probiotics that address:
Digestive Health: solutions to restore ideal balance of gastrointestinal microflora
Immune Health: helps maintain natural immune defenses and support general well-being
Women's Health: clinically-documented to help maintain vaginal health
For more than 30 years, DuPont Nutrition and Health has been a global leader in the science, research and production of probiotics. The company offers the same expertise to customers in South Asia with a key differentiator of quality manufacturing, customization, application and regulatory support and its science substantiation.
"Strengthening our commitment to the probiotics industry, we have globally invested USD 100 million to increase our probiotics production, while we continue to maintain the high potency, stability and efficacy in our products. We have the capability to help our customers launch a probiotic solution in a matter of months in India," said Parth Patel, business director, DuPont Nutrition and Health, South Asia.
"Our HOWARU premium probiotics have been proven safe and efficacious in multiple gold standard, human clinical studies. They are scientifically formulated to provide condition-specific benefits backed by targeted clinical research. Using our FloraFITÂ® range, the end products meet the specific needs of your customers," says Anurag Jain, sales director, DuPont Nutrition and Health, South Asia.
With the wide range of DuPont Danisco premium probiotics, customers will experience -
A wide range of stable, clinically documented probiotics
Specialized sales and technical support
Expert legal and regulatory support
Finished product format options
Visit us at CPhI India (21-23 November, 2016)
Reinforcing its deep market knowledge, product insights and innovative science know-how, the company will showcase a range of health-enhancing benefits at CPhI India 2016 from 21-23 November in Mumbai, India. At the event, visitors will interact with experts on the range of DuPontâ„¢ DaniscoÂ® products. The platform will provide an opportunity to experience the company's healthier profile of OTC nutrition and dietary supplements that address consumer needs in sync with emerging health trends. This will include products and solutions in the range of Probiotics, OSMOAIDÂ® Lactitol and LitesseÂ®.
DuPont will be present at CPhI India in collaboration with Indian distributor S.A. Pharmachem in exhibition hall No. 1, Booth H-13. (ANI)
- Marathon Pharma to sell decades-old drug to treat DMD for $89,000
- FedEx Launches FedEx Fulfillment for Small Business to Compete with Amazon
- CDC updates 2017 advisory for recommended flu shots
- Coca-Cola Helped by Strong North American Demand but Company Issues Lackluster Future Guidance
- Women with dense breasts more likely to develop breast cancer: study